Grace Therapeutics, Stock Price on November 12, 2024
| GRCE Stock | 3.28 0.05 1.55% |
Below is the normalized historical share price chart for Grace Therapeutics, extending back to February 07, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Grace Therapeutics, stands at 3.28, as last reported on the 22nd of November, with the highest price reaching 3.38 and the lowest price hitting 3.07 during the day.
If you're considering investing in Grace Stock, it is important to understand the factors that can impact its price. Grace Therapeutics, appears to be very risky, given 3 months investment horizon. Grace Therapeutics, holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13% return per unit of standard deviation over the last 3 months. By evaluating Grace Therapeutics,'s technical indicators, you can evaluate if the expected return of 0.61% is justified by implied risk. Please utilize Grace Therapeutics,'s market risk adjusted performance of (1.74), and Risk Adjusted Performance of 0.0929 to validate if our risk estimates are consistent with your expectations.
At present, Grace Therapeutics,'s Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 13.4 M, whereas Total Stockholder Equity is forecasted to decline to about 58.7 M. . Grace Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of October 2024 |
Grace |
Sharpe Ratio = 0.1309
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GRCE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.68 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.61 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Grace Therapeutics, is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Grace Therapeutics, by adding it to a well-diversified portfolio.
Related Headline
Ecolab Headline on 12th of November 2024
OVERSEA CHINESE BANKING Corp Ltd Sells 24,514 Shares of Ecol... by thelincolnianonline.com
OVERSEA CHINESE BANKING Corp Ltd lowered its position in shares of Ecolab Inc. by 14.8 percent in the 3rd quarter, according to its most recent Form 13F filing with the Securities Exchange Commission. The institutional investor owned 140,879 shares of the basic materials companys stock after selling 24,514 shares during the
Grace Therapeutics, Valuation on November 12, 2024
It is possible to determine the worth of Grace Therapeutics, on a given historical date. On November 12, 2024 Grace was worth 3.15 at the beginning of the trading date compared to the closed value of 3.19. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Grace Therapeutics, stock. Still, in general, we apply an absolute valuation method to find Grace Therapeutics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Grace Therapeutics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Grace Therapeutics,'s related companies.
| Open | High | Low | Close | Volume | |
| 3.00 | 3.25 | 2.95 | 3.05 | 45,334 | |
11/12/2024 | 3.15 | 3.27 | 3.05 | 3.19 | 24,269 |
| 3.11 | 3.34 | 3.03 | 3.05 | 29,609 |
| Backtest Grace Therapeutics, | | | Grace Therapeutics, History | | | Grace Therapeutics, Valuation | Previous | Next |
Grace Therapeutics, Trading Date Momentum on November 12, 2024
| On November 13 2024 Grace Therapeutics, was traded for 3.05 at the closing time. The top price for the day was 3.34 and the lowest listed price was 3.03 . The trading volume for the day was 29.6 K. The trading history from November 13, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.39% . The overall trading delta against the current closing price is 0.31% . |
Grace Therapeutics, Fundamentals Correlations and Trends
By evaluating Grace Therapeutics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Grace Therapeutics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Grace financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Grace Therapeutics, Stock history
Grace Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Grace is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Grace Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Grace Therapeutics, stock prices may prove useful in developing a viable investing in Grace Therapeutics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 9.4 M | 7.9 M |
Grace Therapeutics, Quarterly Net Working Capital |
|
Grace Therapeutics, Stock Technical Analysis
Grace Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Grace Therapeutics, Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Grace Therapeutics, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Grace Therapeutics, November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Grace Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Grace Therapeutics, shares will generate the highest return on investment. By undertsting and applying Grace Therapeutics, stock market strength indicators, traders can identify Grace Therapeutics, entry and exit signals to maximize returns
Grace Therapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Grace Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Grace Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Grace to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0929 | |||
| Jensen Alpha | 0.5339 | |||
| Total Risk Alpha | (0.10) | |||
| Sortino Ratio | 0.1204 | |||
| Treynor Ratio | (1.75) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Grace Stock analysis
When running Grace Therapeutics,'s price analysis, check to measure Grace Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grace Therapeutics, is operating at the current time. Most of Grace Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Grace Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grace Therapeutics,'s price. Additionally, you may evaluate how the addition of Grace Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |